SCHEMBL25633236

SCHEMBL25633236

CCN1CCC2(CC1)CN(c1ncnc3ccc(CC(F)(F)F)cc13)C2

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 4/20 0.52
▸ ALDH1A1 P00352 2/20 0.49
▸ NPSR1 Q6W5P4 1/20 0.49
▸ MEN1 O00255 14/20 0.46
▸ KMT2A Q03164 5/20 0.45
▸ ACHE P22303 2/20 0.37
▸ BACE1 P56817 2/20 0.37
▸ AURKA O14965 1/20 0.37
▸ USP2 O75604 1/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ MAPK1 P28482 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ HIF1A Q16665 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25716737 0.89 HTT (0.46) HTTALDH1A1MEN1KMT2AUSP2
SCHEMBL30455675 0.87 MEN1 (0.51) HTTMEN1KMT2AACHEBACE1
SCHEMBL25629403 0.85 HTT (0.46) HTTALDH1A1NPSR1MEN1KMT2A
SCHEMBL30455740 0.84 HTT (0.44) HTTALDH1A1MEN1KMT2AUSP2
SCHEMBL25222339 0.84 HTT (0.44) HTTALDH1A1MEN1KMT2AUSP2
SCHEMBL19032225 0.84 MEN1 (0.46) HTTALDH1A1NPSR1MEN1KMT2A
SCHEMBL25224450 0.84 MEN1 (0.44) MEN1KMT2ACYP3A4
SCHEMBL25633293 0.83 HTT (0.52) HTTALDH1A1NPSR1MEN1KMT2A
SCHEMBL31501671 0.83 MEN1 (0.49) HTTMEN1KMT2AACHEBACE1
Hydrochloric Acid SCHEMBL25278259 0.83 HTT (0.43) HTTALDH1A1MEN1KMT2AUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023107687-A1 INHIBITORS OF MENIN-MLL INTERACTION BALA THERAPEUTICS, INC. (US) 2023-06-15 — — WO disclosed
WO-2023107696-A2 INHIBITORS OF MENIN-MLL INTERACTION BALA THERAPEUTICS, INC. (US) 2023-06-15 — — WO disclosed
Send feedback